ADVANCED ENZYME TECHNOLOGIES
Back to Cashflow Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹142 Cr | ₹141 Cr | ₹140 Cr | ₹122 Cr | ₹163 Cr |
What is the latest Cash Flow from Operating Activities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹142 Cr |
| Mar2024 | ₹141 Cr |
| Mar2023 | ₹140 Cr |
| Mar2022 | ₹122 Cr |
| Mar2021 | ₹163 Cr |
How is Cash Flow from Operating Activities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹142 Cr | 0.80 | |
| Mar2024 | ₹141 Cr | 0.72 | |
| Mar2023 | ₹140 Cr | 14.78 | |
| Mar2022 | ₹122 Cr | -24.96 | |
| Mar2021 | ₹163 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹4,203.4 Cr | 3.2% | 25.4% | 32% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 3.2% |
25.4% |
32% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses